Search Results
Jul 20, 2026, 03:42 ET Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
period followed by the optional open-label extension.About DEEsDevelopmental and Epileptic Encephalopathies (DEEs) are a group of rare neurodevelopmental disorders that typically manifest in early childhood.1 These heterogeneous and severe epilepsy syndromes are characterized
More news about: H. Lundbeck A/S
Jul 18, 2026, 14:55 ET REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic
More news about: REGENXBIO Inc.
Jul 18, 2026, 10:59 ET GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
HOLDINGS CORP. CLASS ACTION LAWSUIT – COMPLAINT ALLEGATION SUMMARY:GeneDx provides genetic testing services for diagnosing pediatric and rare diseases. The class period begins on April 16, 2025, when GeneDx announced that it entered into an agreement worth up to $51 million to acquire Fabric
More news about: Kessler Topaz Meltzer & Check, LLP
Jul 17, 2026, 13:28 ET Mercedes-Benz of Arrowhead Highlights Selection of Custom and Highly Optioned Mercedes-Benz G-Class Models in Peoria, Arizona
Mercedes-Benz G-Class SUVs, offering luxury vehicle shoppers from Peoria access to an inventory that frequently includes rare configurations, premium factory equipment and sought-after pre-owned models.
More news about: Mercedes-Benz of Arrowhead
Jul 17, 2026, 11:13 ET GAIR, GAIR, CONASON, RUBINOWITZ, BLOOM, HERSHENHORN, STEIGMAN & MACKAUF FILES WRONGFUL DEATH LAWSUIT AGAINST CONSOLIDATED EDISON OVER UNCOVERED MANHOLE THAT KILLED MANHATTAN WOMAN
dislodged the manhole cover just 12 minutes before Ms. Gocaj fell through the open shaft."Donike Gocaj's death was not a tragic accident or a rare occurrence, as Con Edison claims," said
More news about: Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf
Jul 17, 2026, 10:15 ET Bioinformatics Market worth $34.41 billion by 2031 - Exclusive Report by MarketsandMarkets™
intelligence (AI) and machine learning (ML) in multi-omics research is enabling better data integration, 1odelling, and analytics. Research in cancer genomics, rare disease research, immunology, and systems biology is anticipated to drive adoption of multi-omics data integration solutions.Pharmaceutical
More news about: MarketsandMarkets
Jul 17, 2026, 09:45 ET A Greenland Deposit Just Got Its First U.S.-Compliant Resource Report, and the Indicated Grade Jumped 36%
exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, advancing what it calls a North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure. The Sarfartoq rare earths addition
More news about: Equity Insider
Jul 17, 2026, 07:00 ET DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY
with a promising pharmacokinetic profile.Building a focused, rare kidney disease portfolioThe acquisition of DMX-652 aligns with Dimerix's strategy to build a focused pipeline of effective treatments for rare kidney diseases with high unmet medical needs. The DMX-652 program is a
More news about: Dimerix Limited
Jul 17, 2026, 07:00 ET REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants
its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic
More news about: REGENXBIO Inc.
Jul 17, 2026, 05:27 ET Forevermark Diamond Jewellery Strengthens South India presence with its first store in Bengaluru
milestones. Rooted in rarity, authenticity and transparency, every piece is created using some of the world's most beautiful natural diamonds that are rare, responsibly sourced and brought to life through timeless design and exceptional craftsmanship. Reflecting the brand's vision of delivering immersive
More news about: Forevermark Diamond Jewellery
Jul 17, 2026, 01:25 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
[email protected] acromegalyAcromegaly is a rare, slowly progressive disease, typically caused by a tumor of the pituitary gland producing excess growth hormone and stimulating increased insulin growth
More news about: Camurus AB
Jul 17, 2026, 01:22 ET Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
[email protected] acromegalyAcromegaly is a rare, slowly progressive disease, typically caused by a tumor of the pituitary gland producing excess growth hormone and stimulating increased insulin growth
More news about: Camurus AB
Jul 16, 2026, 21:03 ET The Chef's Table and The Tasting Room to Expand into Winter Garden's Historic Bond Building
character of the communities where it operates. In addition to restoring irreplaceable landmarks, under Larweth's leadership the company is undertaking the rare work of reconstructing in exacting detail iconic historic buildings lost to time. Active projects span Winter Garden, FL; Tempe, AZ; and Nashville,
More news about: Anton Hospitality Holdings
Jul 16, 2026, 16:30 ET Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe
with GPP.The EMA's orphan drug designation is granted to medicines intended for the treatment of life-threatening or chronically debilitating rare conditions affecting fewer than 5 in 10,000 people in the EU. Benefits include protocol assistance, reduced regulatory fees, and market exclusivity
More news about: Vanda Pharmaceuticals Inc.
Jul 16, 2026, 16:26 ET REGENXBIO Announces Proposed Public Offering of Common Stock
its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic
More news about: REGENXBIO Inc.
Jul 16, 2026, 13:00 ET Wafra Deepens Strategic Partnership with Ardian
the firm's leadership, culture and long-term growth trajectory", said Adel Alderbas, Chief Investment Officer at Wafra. "We were delighted to have the rare opportunity to partner with Ardian last year and have collaborated closely with the firm's leadership since then. Even in the short time since becoming
More news about: Wafra
Jul 16, 2026, 13:00 ET Wafra Deepens Strategic Partnership with Ardian
the firm's leadership, culture and long-term growth trajectory", said Adel Alderbas, Chief Investment Officer at Wafra. "We were delighted to have the rare opportunity to partner with Ardian last year and have collaborated closely with the firm's leadership since then. Even in the short time since becoming
More news about: Wafra
Jul 16, 2026, 12:27 ET Pebble Beach Concours d'Elegance Reveals Official Poster Collection for Its 75th Celebration
aerodynamic resistance. The three BATs (shown left to right: BAT 9, BAT 7, and BAT 5) captivated enthusiasts and constructor Nuccio Bertone alike, who saw a rare glimpse of all his creations together for the first time. This year the BATs return to Pebble Beach, once again united in a historic gathering that
More news about: Pebble Beach Concours d'Elegance
Jul 16, 2026, 12:26 ET Jay Walker Hit Podcast Expands to 4 Days a Week, Sets Premiere Date & Names Sean Atkins EP
an absolute force in media, and we are thrilled to completely double down on his vision," said Erin, Chief Executive Officer of Audio One. "He has a rare, undeniable talent for cutting through the noise and shifting the culture with every single episode. Moving
More news about: A1 LLC
Jul 16, 2026, 12:25 ET Raymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)
it demonstrates statistically significant effects on diplopia response and complete resolution of diplopia in clinical studies.Thryoid eye disease (TED) is a rare autoimmune condition that can cause proptosis, diplopia, pain, soft tissue inflammation, and, in severe cases, total loss of vision. For ophthalmology
More news about: Dr. Raymond Douglas, MD, PhD
Jul 16, 2026, 12:12 ET /C O R R E C T I O N -- Overlord Labs/
Analog Group, retiring in 2017. His experience taking battery management silicon from architecture through high-volume production gives Overlord Labs rare, domain-specific guidance as GENESIS™ scales beyond first silicon.As compute continues moving to the edge, battery-powered devices are placing
More news about: Overlord Labs
Jul 16, 2026, 11:00 ET JetZero Appoints Pat Shanahan and Eric Hirshberg to Board of Directors
"Pat and Eric each bring a caliber of experience that is rare and exactly what JetZero needs as we move from demonstrator to production," said Tom O'Leary, co-founder and CEO of JetZero. "Pat's unmatched knowledge
More news about: JetZero
Jul 16, 2026, 10:30 ET Oligonucleotide Synthesis Market worth $32.72 billion by 2031 - Exclusive Report by MarketsandMarkets™
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350Key drivers of market growth include rising demand for oligonucleotide-based drugs such as ASOs and siRNAs to treat neurological and rare disorders, including Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), and hepatic veno-occlusive disease (VOD), as well as technological
More news about: MarketsandMarkets
Jul 16, 2026, 10:00 ET Whale Raises $40M Series C3 Extension, Bringing Total Series C to $100M, to Scale Global Enterprise AI Operations
a clear direction in enterprise AI, and Jerry and his team have demonstrated the ability to execute across complex, real-world deployments, which is rare at this scale," said Dr. Zhang Guoyong, General Manager of the Private Equity Investment Management Department, CMBI. "We see long-term potential in
More news about: Whale
Jul 16, 2026, 09:39 ET /C O R R E C T I O N -- Global Travel Collection/
faces joining the cast. This season, the hit NBC series heads to Brussels, Belgium, with a fresh lineup of advisors and celebrity clients, offering a rare behind-the-scenes look at the world of elite luxury travel planning. New episodes are set to premiere on NBC stations nationwide in October 2026.
More news about: Global Travel Collection